HeartSciences (HSCS) Proxy filing summary

Executive summary

• Fortitude and HeartSciences have agreed to merge in an all-stock transaction, combining digital asset mining and AI-powered medical technology operations.

• The merger is expected to close in the second half of 2026, pending shareholder approval and satisfaction of closing conditions.

• Communications emphasize that forward-looking statements are subject to risks, including market volatility, regulatory uncertainty, and integration challenges.

Voting matters and shareholder proposals

• HeartSciences shareholders will vote on the proposed merger at a special meeting, with proxy materials to be mailed after SEC filing.

• Directors, executive officers, and certain Digital Currency Group executives may participate in proxy solicitation.

Board of directors and corporate governance

• Information about directors and executive officers, including their stock ownership, is disclosed in the 2026 Annual Meeting proxy statement.

• Details on participants' interests in the merger will be included in future proxy materials.